OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
13
Results
Show all
Save search
Copy query
Show results for
Unknown
(13)
Publication Date
Release Date
2025
(4)
2023
(3)
2021
(3)
2022
(2)
2019
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594
|
biostudies-literature
Cite
Cell-type-specific DNA methylation dynamics in the prenatal and postnatal human cortex.
Not available
S-EPMC12802690
|
biostudies-literature
Cite
Surgical outcomes from haematoma evacuation for intracerebral haemorrhage in the INTERACT3 study.
Not available
S-EPMC12414919
|
biostudies-literature
Cite
Global variation in anastomosis and end colostomy formation following left-sided colorectal resection.
Not available
S-EPMC6921967
|
biostudies-literature
Cite
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial.
Not available
S-EPMC10401723
|
biostudies-literature
Cite
Polygenic and developmental profiles of autism differ by age at diagnosis.
Not available
S-EPMC12571882
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Whole-genome sequencing reveals host factors underlying critical COVID-19.
Not available
S-EPMC9259496
|
biostudies-literature
Cite
Mapping the human genetic architecture of COVID-19.
Not available
S-EPMC8674144
|
biostudies-literature
Cite
A second update on mapping the human genetic architecture of COVID-19.
Not available
S-EPMC10482689
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets